Count | |
2 | |
14 | |
1 | |
4 | |
2 | |
1 | |
1 | |
1 | |
1 | |
1 | |
2 | |
2 | |
1 | |
1 | |
1 | |
HIV Protease Inhibitors/blood/pharmacokinetics/*therapeutic use | 1 |
1 | |
1 | |
HIV Protease Inhibitors/blood/*pharmacokinetics/therapeutic use | 1 |
1 | |
1 | |
HIV Protease Inhibitors/adverse effects/blood/*pharmacokinetics | 1 |
HIV Protease Inhibitors/*administration & dosage/*blood/pharmacokinetics | 1 |
HIV Protease Inhibitors/blood/cerebrospinal fluid/*pharmacokinetics | 2 |
HIV Protease Inhibitors/administration & dosage/*blood/therapeutic use | 1 |
HIV Protease Inhibitors/administration & dosage/blood/*pharmacokinetics | 2 |
HIV Protease Inhibitors/adverse effects/blood/*therapeutic use | 1 |
1 | |
17 | |
11 | |
2 | |
5 | |
19 | |
30 | |
1 | |
7 | |
4 | |
28 | |
50 | |
5 | |
1 | |
3 | |
2 | |
13 | |
1 | |
113 | |
1 | |
2 | |
217 | |
2 | |
65 | |
25 | |
2 | |
2 | |
1 | |
17 | |
5 | |
1 | |
1 | |
1 | |
2 | |
3 | |
1 | |
1 | |
3 | |
1 | |
1 | |
4 | |
2 | |
2 | |
1 | |
1 | |
3 | |
2 | |
1 | |
4 | |
2 | |
1 | |
2 | |
1 | |
1 | |
1 | |
1 | |
5 | |
1 | |
1 | |
1 | |
2 | |
4 | |
1 | |
3 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
5 | |
3 | |
1 | |